Exploring cognitive progression subtypes in the Framingham Heart Study.

Alzheimer’s disease (AD) is a heterogeneous disorder characterized by complex underlying neuropathology that is not fully understood. This study aimed to identify cognitive progression subtypes and examine their correlation with clinical outcomes.